Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Hauptman-Woodward Medical Research Institute (HWI) is an independent, non-profit biomedical research facility located in Buffalo, New York, specializing in structural biology. Founded in 1956, the institute gained international prominence when its former president, Dr. Herbert Hauptman, was awarded the Nobel Prize in Chemistry for developing direct methods for determining crystal structures. HWI operates the world-renowned High-Throughput Crystallization Screening Center, which provides essential services to the global scientific community to facilitate drug discovery and development. The institute's research focuses on using X-ray crystallography and cryo-electron microscopy to understand the molecular basis of diseases such as cancer and COVID-19. As a founding member of the Buffalo Niagara Medical Campus, HWI collaborates extensively with academic and clinical partners to translate basic structural research into therapeutic insights.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hauptman-Woodward Medical Research Institute.